scholarly journals Cribriform-Morular Variant of Papillary Thyroid Carcinoma Shows High Ki-67 Labeling Indices, despite Its Excellent Prognosis

Pathobiology ◽  
2019 ◽  
Vol 86 (5-6) ◽  
pp. 248-253 ◽  
Author(s):  
Mitsuyoshi Hirokawa ◽  
Katsuya Matsuda ◽  
Takumi Kudo ◽  
Miyoko Higuchi ◽  
Ayana Suzuki ◽  
...  
2022 ◽  
Vol 5 (1) ◽  
Author(s):  
Kusum L. Sharma ◽  
Ravi B. Singh ◽  
Nisreen Fidda ◽  
Ricardo V. Lloyd

Abstract Introduction Cribrifrom-morular variant of papillary thyroid carcinoma (CMVPTC) is an uncommon thyroid neoplasm that occurs predominantly in women and is sometime associated with familial adenomatous polyposis (FAP). Some of these tumors may undergo dedifferentiation to poorly differentiated thyroid carcinoma (PDTC). We describe a rare case of this carcinoma in a women without a history of FAP. Case presentation A 49-year-old woman with a history of breast carcinoma presented with a thyroid mass. A CMVPTC was diagnosed after excision. There was no history of FAP. Histological examination showed classical features of CMVPTC in most areas, but about 20% of the carcinoma showed features of a poorly differentiated carcinoma with a solid pattern of growth, increase mitotic activity and a high Ki-67 proliferative index (25%). Immunohistochemical stains were positive for nuclear and cytoplasmic beta catenin staining. These special studies supported the diagnosis. Conclusion CMVPTC with dedifferentiation to PDTC is a rare carcinoma with only 4 previous documented cases in the literature. This aggressive variant of thyroid carcinoma is more common in females, as is CMVPTC, and is often associated with an aggressive biological course. The cases usually express nuclear beta catenin and estrogen, progesterone and androgen receptors have been reported in some cases. Some cases may have somatic alterations of the APC gene and TERT promoter mutations. These carcinomas may metastasize to lung, bones and lymph nodes. Because of its aggressive behavior, patient with this diagnosis should be treated aggressively to control disease spread and mortality from the carcinoma.


2009 ◽  
Vol 9 (1) ◽  
pp. 7 ◽  
Author(s):  
Seung Hwan Lee ◽  
Seung Yeon Park ◽  
Na Rai Kim ◽  
Young Don Lee

Pathology ◽  
2009 ◽  
Vol 41 (5) ◽  
pp. 509-512 ◽  
Author(s):  
Yingchun Dong ◽  
Xiaojun Zhou ◽  
Honglin Yin ◽  
Jiandong Wang ◽  
Hangbo Zhou ◽  
...  

2009 ◽  
Vol 131 (1) ◽  
pp. 134-142 ◽  
Author(s):  
José Cameselle-Teijeiro ◽  
Lia P. Menasce ◽  
Beng K. Yap ◽  
Rovel J. Colaco ◽  
Patricia Castro ◽  
...  

2014 ◽  
Vol 13 (4) ◽  
pp. 547-551 ◽  
Author(s):  
Rachel A. Levy ◽  
Vanessa W. Hui ◽  
Rupa Sood ◽  
Stephanie Fish ◽  
Arnold J. Markowitz ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
David F. Schaeffer ◽  
Eric M. Yoshida ◽  
David A. Owen ◽  
Kenneth W. Berean

It has been well established in the literature that the cribriform-morular variant of papillary thyroid carcinoma (CMVPTC) has been observed with higher frequency in familial adenomatous polyposis (FAP) patients. In the usual setting, patients with FAP are identified based on their germline mutations and the diagnosis of thyroid neoplasm is made after the FAP diagnosis. We herein report a case in which the recognition of a CMVPTC led to the initial diagnosis of FAP. The histological and clinical features of CMVPTC are reviewed with emphasis on its relationship to FAP.


Sign in / Sign up

Export Citation Format

Share Document